Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Klotho Neurosciences ROA 2022-2025 | KLTO

Current and historical return on assets (ROA) values for Klotho Neurosciences (KLTO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Klotho Neurosciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-06-30 $-0.01B $0.01B -244.44%
2025-03-31 $-0.01B $0.00B -280.00%
2024-12-31 $-0.01B $0.00B -88.89%
2024-09-30 $-0.01B $0.00B -74.07%
2024-06-30 $0.00B $0.00B -9.64%
2024-03-31 $0.00B $0.02B -5.84%
2023-12-31 $0.00B $0.00B 0.00%
2023-09-30 $0.00B $0.06B 2.27%
2023-06-30 $0.00B $0.06B 2.91%
2023-03-31 $0.00B $0.12B 2.54%
2022-12-31 $0.00B $0.12B 2.27%
2022-06-30 $0.00B $0.12B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.036B $0.000B
Klotho Neurosciences Inc. is a pharmaceutical company. It specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system which are seen as key developments in treating neurodegenerative and age-related disorders. Klotho Neurosciences Inc., formerly known as ANEW MEDICAL INC., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.859B 31.85
Zoetis (ZTS) United States $53.434B 19.12
Takeda Pharmaceutical (TAK) Japan $44.834B 9.15
Daiichi Sankyo, - (DSNKY) Japan $42.623B 21.23
BeOne Medicines - (ONC) Switzerland $41.395B 219.46
Sandoz Group AG (SDZNY) Switzerland $30.417B 0.00
United Therapeutics (UTHR) United States $19.872B 17.49
Merck (MKKGY) Germany $17.383B 11.30
Shionogi (SGIOY) Japan $14.751B 13.55
Neurocrine Biosciences (NBIX) United States $14.642B 35.13
Summit Therapeutics (SMMT) United States $14.521B 0.00
IPSEN (IPSEY) France $12.599B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.013B 0.00
Ionis Pharmaceuticals (IONS) United States $11.771B 0.00
Orion OYJ (ORINY) Finland $9.625B 27.50
Eisai (ESAIY) $8.295B 0.00
Corcept Therapeutics (CORT) United States $8.246B 89.08
Stevanato Group S.p.A (STVN) Italy $7.171B 40.14
Grifols, S.A (GRFS) Spain $5.975B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.315B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.063B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.738B 17.76
Centessa Pharmaceuticals (CNTA) United Kingdom $3.575B 0.00
Hypermarcas (HYPMY) Brazil $3.161B 21.70
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.800B 8.93
Dyne Therapeutics (DYN) United States $2.658B 0.00
Soleno Therapeutics (SLNO) United States $2.564B 0.00
Ocular Therapeutix (OCUL) United States $2.448B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.049B 24.28
Guardian Pharmacy Services (GRDN) United States $1.998B 38.48
Avadel Pharmaceuticals (AVDL) Ireland $1.859B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.512B 89.75
Collegium Pharmaceutical (COLL) United States $1.497B 7.41
Ardelyx (ARDX) United States $1.468B 0.00
Harrow (HROW) United States $1.424B 87.36
Amylyx Pharmaceuticals (AMLX) United States $1.354B 0.00
Xeris Biopharma Holdings (XERS) United States $1.259B 0.00
Enliven Therapeutics (ELVN) United States $1.202B 0.00
Oruka Therapeutics (ORKA) United States $1.176B 0.00
Nektar Therapeutics (NKTR) United States $1.173B 0.00
Evotec AG (EVO) Germany $1.115B 0.00
Relay Therapeutics (RLAY) United States $1.069B 0.00
Xencor (XNCR) United States $1.028B 0.00
Cronos Group (CRON) Canada $0.973B 0.00
Theravance Biopharma (TBPH) United States $0.895B 37.83
ARS Pharmaceuticals (SPRY) United States $0.884B 0.00
Organogenesis (ORGO) United States $0.822B 0.00
ProKidney (PROK) United States $0.789B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.725B 6.47
Esperion Therapeutics (ESPR) United States $0.724B 0.00
Elite Pharmaceuticals (ELTP) United States $0.717B 0.00
Savara (SVRA) United States $0.712B 0.00
Aquestive Therapeutics (AQST) United States $0.681B 0.00
KalVista Pharmaceuticals (KALV) United States $0.674B 0.00
Bioventus (BVS) United States $0.632B 12.97
4D Molecular Therapeutics (FDMT) United States $0.627B 0.00
Zevra Therapeutics (ZVRA) United States $0.529B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.505B 11.96
Lexeo Therapeutics (LXEO) United States $0.497B 0.00
Akebia Therapeutics (AKBA) United States $0.491B 0.00
Siga Technologies (SIGA) United States $0.445B 6.09
Altimmune (ALT) United States $0.441B 0.00
Galectin Therapeutics (GALT) United States $0.376B 0.00
Nature's Sunshine Products (NATR) United States $0.362B 21.55
USANA Health Sciences (USNA) United States $0.354B 9.89
Lyell Immunopharma (LYEL) United States $0.339B 0.00
Aldeyra Therapeutics (ALDX) United States $0.319B 0.00
Korro Bio (KRRO) United States $0.295B 0.00
Larimar Therapeutics (LRMR) United States $0.279B 0.00
Pyxis Oncology (PYXS) United States $0.272B 0.00
Aclaris Therapeutics (ACRS) United States $0.261B 0.00
Achieve Life Sciences (ACHV) Canada $0.251B 0.00
Journey Medical (DERM) United States $0.239B 0.00
AleAnna (ANNA) United States $0.230B 0.00
OmniAb (OABI) United States $0.226B 0.00
Protara Therapeutics (TARA) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Avalo Therapeutics (AVTX) United States $0.203B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
Cassava Sciences (SAVA) United States $0.157B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.155B 0.00
China SXT Pharmaceuticals (SXTC) China $0.153B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.137B 0.00
Relmada Therapeutics (RLMD) United States $0.130B 0.00
Incannex Healthcare (IXHL) Australia $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.121B 0.00
Avita Medical (RCEL) United States $0.115B 0.00
Surrozen (SRZN) United States $0.111B 0.00
Context Therapeutics (CNTX) United States $0.108B 0.00
Gain Therapeutics (GANX) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
Vivani Medical (VANI) United States $0.097B 0.00
Karyopharm Therapeutics (KPTI) United States $0.095B 0.00
Champions Oncology (CSBR) United States $0.095B 34.35
Unicycive Therapeutics (UNCY) United States $0.091B 0.00
Dominari Holdings (DOMH) United States $0.087B 0.00
VAXART, INC (VXRT) United States $0.087B 0.00
Assertio Holdings (ASRT) United States $0.083B 0.00
Prelude Therapeutics (PRLD) United States $0.083B 0.00
Plus Therapeutics (PSTV) United States $0.077B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Acrivon Therapeutics (ACRV) United States $0.072B 0.00
Lite Strategy (LITS) United States $0.072B 0.00
Nutriband (NTRB) United States $0.071B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Talphera (TLPH) United States $0.060B 0.00
BioNxt Solutions (BNXTF) Canada $0.060B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
Fractyl Health (GUTS) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Wellgistics Health (WGRX) United States $0.051B 0.00
Arch Biopartners (ACHFF) Canada $0.050B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
Inotiv (NOTV) United States $0.038B 0.00
FibroGen (FGEN) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.036B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 26.75
Liminatus Pharma (LIMN) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Cosmos Health (COSM) United States $0.026B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Vyome Holdings (HIND) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Mangoceuticals (MGRX) United States $0.019B 0.00
Heatwurx (PCSA) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.02
BioLineRx (BLRX) Israel $0.015B 0.00
Ainos (AIMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00